Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.
- Status
- COMPLETED
- Phase
- PHASE3
Wearable Sensors in Knee OA
- Status
- COMPLETED
- Phase
- NA
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of LY3478006 in Healthy Participants
- Status
- TERMINATED
- Phase
- PHASE1
Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3526318 in Healthy Women
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
A Safety Study of LY3493269 Given as a Single Injection in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2